DK0428105T3 - Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til hindring af infektioner med vira omhyllet med glycoprotein - Google Patents

Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til hindring af infektioner med vira omhyllet med glycoprotein

Info

Publication number: DK0428105T3
Authority: DK; Denmark
Prior art keywords: ones; infections; isoquinolyloxazol; quinolyl; glycoprotein
Prior art date: 1989-11-13

Application number

DK90121632.5T

Other languages

Danish (da)

English (en)

Inventor

Sai P Sunkara

Winton D Jones

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-13

Filing date

1990-11-12

Publication date

1994-02-28

1990-11-12 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1994-02-28 Application granted granted Critical

1994-02-28 Publication of DK0428105T3 publication Critical patent/DK0428105T3/da

Links

241000700605 Viruses Species 0.000 title abstract 2
ZINIIQBSXNSVBO-UHFFFAOYSA-N 4-isoquinolin-1-yl-3h-1,3-oxazol-2-one Chemical class O1C(=O)NC(C=2C3=CC=CC=C3C=CN=2)=C1 ZINIIQBSXNSVBO-UHFFFAOYSA-N 0.000 title 1
102000003886 Glycoproteins Human genes 0.000 title 1
108090000288 Glycoproteins Proteins 0.000 title 1
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
230000002265 prevention Effects 0.000 title 1
125000005493 quinolyl group Chemical group 0.000 title 1
208000030507 AIDS Diseases 0.000 abstract 1
208000031886 HIV Infections Diseases 0.000 abstract 1
229940123924 Protein kinase C inhibitor Drugs 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000003881 protein kinase C inhibitor Substances 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK90121632.5T 1989-11-13 1990-11-12 Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til hindring af infektioner med vira omhyllet med glycoprotein DK0428105T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US43531889A	1989-11-13	1989-11-13

Publications (1)

Publication Number	Publication Date
DK0428105T3 true DK0428105T3 (da)	1994-02-28

Family

ID=23727911

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90121632.5T DK0428105T3 (da)	1989-11-13	1990-11-12	Anvendelse af quinolyl- og isoquinolyloxazol-2-oner til fremstilling af et lægemiddel til hindring af infektioner med vira omhyllet med glycoprotein

Country Status (11)

Country	Link
EP (1)	EP0428105B1 (fr)
JP (1)	JP2927930B2 (fr)
KR (1)	KR0162639B1 (fr)
AT (1)	ATE100318T1 (fr)
AU (1)	AU630249B2 (fr)
DE (1)	DE69006187T2 (fr)
DK (1)	DK0428105T3 (fr)
ES (1)	ES2062266T3 (fr)
IE (1)	IE63851B1 (fr)
PH (1)	PH27309A (fr)
ZA (1)	ZA908933B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6107327A (en) *	1996-08-30	2000-08-22	Eli Lilly And Company	Therapeutic treatment for HIV infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4886811A (en) *	1988-10-24	1989-12-12	Merrell Dow Pharmaceuticals	Qunolyloxazole-2-ones useful as proteinkinase C inhibitors

1990
- 1990-11-03 PH PH41540A patent/PH27309A/en unknown
- 1990-11-07 ZA ZA908933A patent/ZA908933B/xx unknown
- 1990-11-08 AU AU65929/90A patent/AU630249B2/en not_active Ceased
- 1990-11-12 ES ES90121632T patent/ES2062266T3/es not_active Expired - Lifetime
- 1990-11-12 DE DE90121632T patent/DE69006187T2/de not_active Expired - Fee Related
- 1990-11-12 IE IE407990A patent/IE63851B1/en not_active IP Right Cessation
- 1990-11-12 EP EP90121632A patent/EP0428105B1/fr not_active Expired - Lifetime
- 1990-11-12 AT AT90121632T patent/ATE100318T1/de not_active IP Right Cessation
- 1990-11-12 DK DK90121632.5T patent/DK0428105T3/da active
- 1990-11-12 KR KR1019900018247A patent/KR0162639B1/ko not_active Expired - Fee Related
- 1990-11-13 JP JP2304165A patent/JP2927930B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU6592990A (en)	1991-05-16
JP2927930B2 (ja)	1999-07-28
DE69006187D1 (de)	1994-03-03
ES2062266T3 (es)	1994-12-16
KR0162639B1 (ko)	1998-12-01
AU630249B2 (en)	1992-10-22
KR910009260A (ko)	1991-06-28
JPH03173886A (ja)	1991-07-29
IE63851B1 (en)	1995-06-14
PH27309A (en)	1993-05-28
DE69006187T2 (de)	1994-05-05
ZA908933B (en)	1991-08-28
ATE100318T1 (de)	1994-02-15
EP0428105B1 (fr)	1994-01-19
IE904079A1 (en)	1991-05-22
EP0428105A2 (fr)	1991-05-22
EP0428105A3 (en)	1991-12-11

Similar Documents

Publication	Publication Date	Title
EA200201279A1 (ru)	2003-06-26	Способы и композиции для лечения вирусного гепатита c
EA200201263A1 (ru)	2003-06-26	СПОСОБЫ ЛЕЧЕНИЯ ИНФЕКЦИЙ, ВЫЗЫВАЕМЫХ ВИРУСОМ ГЕПАТИТА ДЕЛЬТА, С ИСПОЛЬЗОВАНИЕМ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
EA199901031A1 (ru)	2000-06-26	Производные бензимидазола
ATE219366T1 (de)	2002-07-15	Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
ES2051641B1 (es)	1995-10-01	Procedimientos para la preparacion de compuestos derivados de tiourea.
DK602988A (da)	1989-05-04	Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser
MY151199A (en)	2014-04-30	Substituted diphenyl heterocycles useful for treating hcv infection
MXPA02012443A (es)	2004-09-10	Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
DE69535758D1 (de)	2008-07-03	Lipid-analoge zur behandlung von viralen infektionen
GR3034279T3 (en)	2000-12-29	Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
WO2003051306A3 (fr)	2003-12-18	Nucleosides de n4-acylcytosine-1,3-dioxolane destines au traitement d'infections virales
GR900100048A (el)	1991-06-07	Αντιμετώπιση ασθενειών σχετικών με μολύνσεις HΙV.
ATE230610T1 (de)	2003-01-15	Hiv protease hemmer in pharmazeutischen zusammensetzungen zur behandlung von aids
ES2123156T3 (es)	1999-01-01	Compuestos y procedimientos de inhibicion de hiv y virus semejantes.
DK1053012T3 (da)	2003-11-17	Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner
EA199800526A1 (ru)	1999-04-29	Производные бензимидазола и их применение для лечения вирусных инфекций
DE69004451D1 (de)	1993-12-16	Prophylaxe und Behandlung von Herpesvirus-Infektionen.
DE69019404D1 (de)	1995-06-22	Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
AU630249B2 (en)	1992-10-22	Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones
DE69010523D1 (de)	1994-08-18	Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
UA41338C2 (uk)	2001-09-17	Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
DK0531341T3 (da)	1997-09-22	Anvendelse af leukoregulin til behandling af dyr, der er inficeret med et kappevirus
DK384387D0 (da)	1987-07-23	Erythromycin-derivater til forebyggelse og behandling af sygdomme fremkaldt af virus
ATE255417T1 (de)	2003-12-15	Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
DE69231465D1 (de)	2000-10-26	Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten